Skip to main content
Category

Liver Cancer

CancerCancerFundingImmunotherapyLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearch

Predicting immunotherapy effectiveness in late-stage liver cancer

By | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research

Blood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…

CancerCancerImmunotherapyLiver CancerMedia ReleasesMelanomaMelanoma DiscoveryMelonomaNews & EventsResearchTranslationTumours

WA melanoma research featured at global Oncology congress

By | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, Tumours

Breakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…

awardsCancerCancerFundingLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsOncofetal Ecosystem

NHMRC funding for DEFINER to identify “the right drug for the right patient” in liver cancer

By | awards, Cancer, Cancer, Funding, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Oncofetal Ecosystem

The Harry Perkins Institute's Oncofetal Ecosystem Laboratory, established early in 2021, has received its first NHMRC Ideas Grant in the most recent grants round. This collaborative project run by the…